Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice |
Lee, Dajeong
(Department of Immunology, College of Medicine, Konkuk University)
Park, Young Hwan (Department of Immunology, College of Medicine, Konkuk University) Lee, Ji Eon (Department of Immunology, College of Medicine, Konkuk University) Kim, Hyuk Soon (Department of Immunology, College of Medicine, Konkuk University) Min, Keun Young (Department of Immunology, College of Medicine, Konkuk University) Jo, Min Geun (Department of Immunology, College of Medicine, Konkuk University) Kim, Hyung Sik (Division of Toxicology, College of Pharmacy, Sungkyunkwan University) Choi, Wahn Soo (Department of Immunology, College of Medicine, Konkuk University) Kim, Young Mi (College of Pharmacy, Duksung Women's University) |
1 | Shah, N. P., Kasap, C., Weier, C., Balbas, M., Nicoll, J. M., Bleickardt, E., Nicaise, C. and Sawyers, C. L. (2008) Transient potent BCRABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis. Cancer Cell 14, 485-493. DOI |
2 | Shah, N. P., Nicoll, J. M., Nagar, B., Gorre, M. E., Paquette, R. L., Kuriyan, J. and Sawyers, C. L. (2002) Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell 2, 117-125. DOI |
3 | Siraganian, R. P., de Castro, R. O., Barbu, E. A. and Zhang, J. (2010) Mast cell signaling: the role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants. FEBS Lett. 584, 4933-4940. DOI |
4 | Wang, W., Zhou, Q., Liu, L. and Zou, K. (2012) Anti-allergic activity of emodin on IgE-mediated activation in RBL-2H3 cells. Pharmacol. Rep. 64, 1216-1222. DOI |
5 | Warrington, R., Silviu-Dan, F. and Wong, T. (2018) Drug allergy. Allergy Asthma Clin. Immunol. 14, 60. DOI |
6 | Wedemeyer, J., Tsai, M. and Galli, S. J. (2000) Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12, 624-631. DOI |
7 | Kim, J. D., Kim, D. K., Kim, H. S., Kim, A. R., Kim, B., Her, E., Park, K. H., Kim, H. S., Kim, Y. M. and Choi, W. S. (2013) Morusbombycis extract suppresses mast cell activation and IgE-mediated allergic reaction in mice. J. Ethnopharmacol. 146, 287-293. DOI |
8 | Kneidinger, M., Schmidt, U., Rix, U., Gleixner, K. V., Vales, A., Baumgartner, C., Lupinek, C., Weghofer, M., Bennett, K. L., Herrmann, H., Schebesta, A., Thomas, W. R., Vrtala, S., Valenta, R., Lee, F. Y., Ellmeier, W., Superti-Furga, G. and Valent, P. (2008) The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood 111, 3097-3107. DOI |
9 | Kim, J. W., Lee, J. H., Hwang, B. Y., Mun, S. H., Ko, N. Y., Kim, D. K., Kim, B., Kim, H. S., Kim, Y. M. and Choi, W. S. (2009) Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo. Biochem. Pharmacol. 77, 1506-1512. DOI |
10 | Kitanaka, S., Nakayama, T., Shibano, T., Ohkoshi, E. and Takido, M. (1998) Antiallergic agent from natural sources. Structures and inhibitory effect of histamine release of naphthopyrone glycosides from seeds of Cassia obtusifolia L. Chem. Pharm. Bull. (Tokyo) 46, 1650-1652. DOI |
11 | Krystel-Whittemore, M., Dileepan, K. N. and Wood, J. G. (2016) Mast cell: a multi-functional master cell. Front. Immunol. 6, 620. DOI |
12 | Lee, Y. S., Kang, O. H., Choi, J. G., Oh, Y. C., Keum, J. H., Kim, S. B., Jeong, G. S., Kim, Y. C., Shin, D. W. and Kwon, D. Y. (2010) Synergistic effect of emodin in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. 48, 1285-1290. DOI |
13 |
Lin, S., Cicala, C., Scharenberg, A. M. and Kinet, J. P. (1996) The |
14 | Akin, C. (2017) Mast cell activation syndromes. J. Allergy Clin. Immunol. 140, 349-355. DOI |
15 | Weng, Z., Patel A. B., Panagiotidou, S. and Theoharides, T. C. (2015) The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells. J. Allergy Clin. Immunol. 135, 1044-1052. DOI |
16 | Xiao, J., Xu, M., Hou, T., Huang, Y., Yang, C. and Li, J. (2015) Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling. Mol. Med. Rep. 12, 3249-3256. DOI |
17 | Yamaguchi, M., Sayama, K., Yano, K., Lantz, C. S., Noben-Trauth, N., Ra, C., Costa, J. J. and Galli, S. J. (1999) IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J. Immunol. 162, 5455-5465. |
18 | Begin, P. and Nadeau, K. C. (2014) Epigenetic regulation of asthma and allergic disease. Allergy Asthma Clin. Immunol. 10, 27. DOI |
19 |
Qiao, H., Andrade, M. V., Lisboa, F. A., Morgan, K. and Beaven, M. A. (2006) |
20 | Aketani, S., Teshima, R., Umezzawa, Y. and Sawada, J. (2001) Correlation between cytosolic calcium concentration and degranulation in RBL-2H3 cells in the presence of various concentrations of antigen-specific IgEs. Immunol. Lett. 75, 185-189. DOI |
21 | Atallah, E., Kantarjian, H. and Cortes, J. (2007) Emerging safety issues with imatinib and other Abl tyrosine kinase inhibitors. Clin. Lymphoma Myeloma 7, S105-S112. DOI |
22 | Barnes, P. J. (1999) Therapeutic strategies for allergic diseases. Nature 402, 31-38. |
23 | Minai-Fleminger, Y. and Levi-Schaffer, F. (2009) Mast cells and eosinophils: the two key effector cells in allergic inflammation. Inflamm. Res. 58, 631-638. DOI |
24 | Bradding, P., Walls, A. F. and Holgate, S. T. (2006) The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 117, 1277-1284. DOI |
25 | Lindner, I., Meier, C., Url, A., Unger, H., Grassauer, A., Prieschl-Grassauer, E. and Doerfler, P. (2010) Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation. BMC Immunol. 11, 24. DOI |
26 | Lombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S., Cornelius, L. A., Das, J., Doweyko, A. M., Fairchild, C., Hunt, J. T., Inigo, I., Johnston, K., Kamath, A., Kan, D., Klei, H., Marathe, P., Pang, S., Peterson, R., Pitt, S., Schieven, G. L., Schmidt, R. J., Tokarski, J., Wen, M. L., Wityak, J. and Borzilleri, R. M. (2004) Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J. Med. Chem. 47, 6658-6661. DOI |
27 |
Mastuda, H., Morikawa, T., Ueda, K., Managi, H. and Yoshikawa, M. (2002) Structural requirements of flavonoids for inhibition of antigen-Induced degranulation, |
28 | Masuda, E. S. and Schmitz, J. (2008) Syk inhibitors as treatment for allergic rhinitis. Pulm. Pharmacol. Ther. 21, 461-467. DOI |
29 | Montani, D., Bergot, E., Gunther, S., Savale, L., Bergeron, A., Bourdin, A., Bouvaist, H., Canuet, M., Pison, C., Macro, M., Poubeau, P., Girerd, B., Natali, D., Guignabert, C., Perros, F., O'Callaghan, D. S., Jais, X., Tubert-Bitter, P., Zalcman, G., Sitbon, O., Simonneau, G. and Humbert, M. (2012) Pulmonary arterial hypertension in patients treated by dasatinib. Circulation 125, 2128-2137. DOI |
30 | Mitre, E. and Nutman, T. B. (2006) Basophils, basophilia and helminth infections. Chem. Immunol. Allergy 90, 141-156. DOI |
31 | El-Agamy, D. S. (2012) Targeting c-kit in the therapy of mast cell disorders: current update. Eur. J. Pharmacol. 690, 1-3. DOI |
32 | Bruhns, P., Fremont, S. and Daeron, M. (2005) Regulation of allergy by Fc receptors. Curr. Opin. Immunol. 17, 662-669. DOI |
33 | Charles, N., Watford, W. T., Ramos, H. L., Hellman, L., Oettgen, H. C., Gomez, G., Ryan, J. J., O'Shea, J. J. and Rivera, J. (2009) Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity 30, 533-543. DOI |
34 | Draber, P., Halova, I., Polakovicova, I. and Kawakami, T. (2016) Signal transduction and chemotaxis in mast cells. Eur. J. Pharmacol. 778, 11-23. DOI |
35 | Feinberg, J. G. (1961) Pinnal anaphylaxis: an additional anaphyiactic site. Nature 191, 712. |
36 | Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M. and Tsai, M. (2005) Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749-786. DOI |
37 | Geha, R. S., Jabara, H. H. and Brodeur, S. R. (2003) The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 3, 721-732. DOI |
38 | Murakami, M. and Kudo, I. (2001) Diversity and regulatory functions of mammalian secretory phospholipase A2s. Adv. Immunol. 77, 163-194. |
39 |
Gomez, G. (2019) Current strategies to inhibit high affinity |
40 | Heuchel, R., Berg, A., Tallquist, M., Ahlen, K., Reed, R. K., Rubin, K., Claesson-Welsh, L., Heldin, C. H. and Soriano, P. (1999) Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling. Proc. Natl. Acad. Sci. U.S.A. 96, 11410-11415. DOI |
41 |
Nam, S. T., Park, Y. H., Kim, H. W., Kim, H. S., Lee, D., Lee, M. B., Kim, Y. M. and Choi, W. S. (2017) Suppression of IgE-mediated mast cell activation and mouse anaphylaxis via inhibition of Syk activation by 8-formyl-7-hydroxy-4-methylcoumarin, |
42 | Ovary, Z. (1958) Passive cutaneous anaphylaxis in the mouse. J. Immunol. 81, 355-357. |
43 | Park, Y. H., Kim, D. K., Kim, H. W., Kim, H. S., Lee, D., Lee, M. B., Min, K. Y., Koo, J., Kim, S. J., Kang, C., Kim, Y. M., Kim, H. S. and Choi, W. S. (2018) Repositioning of anti-cancer drug candidate, AZD7762, to an anti-allergic drug suppressing IgE-mediated mast cells and allergic responses via the inhibition of Lyn and Fyn. Biochem. Pharmacol. 154, 270-277. DOI |
44 | Park, Y. H., Kim, H. W., Kim, H. S., Nam, S. T., Lee, D., Lee, M. B., Min, K. Y., Koo, J., Kim, S. J., Kim, Y. M., Kim, H. S. and Choi, W. S. (2019) An anti-cancer drug candidate CYC116 suppresses type I hypersensitive immune responses through the inhibition of Fyn kinase in mast cells. Biomol. Ther. (Seoul) 27, 311-317. DOI |
45 | Horny, H. P., Sotlar, K. and Valent, P. (2007) Mastocytosis: state of the art. Pathobiology 74, 121-132. DOI |
46 | Parravicini, V., Gadina, M., Kovarova, M., Odom, S., Gonzalez-Espinosa, C., Furumoto, Y., Saitoh, S., Samelson, L. E., O'Shea, J. J. and Rivera, J. (2002) Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3, 741-748. DOI |
47 | Randall, K. L. and Hawkins, C. A. (2018) Antihistamines and allergy. Aust. Prescr. 41, 41-45. DOI |
48 |
Rivera, J. (2002) Molecular adapters in |
49 | Hide, I., Toriu, N., Nuibe, T., Inoue, A., Hide, M., Yamamoto, S. and Nakata, Y. (1997) Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. J. Immunol. 159, 2932-2940. |
50 |
Hoffmann, A., Jamin, A., Foetisch, K., May, S., Aulepp, H., Haustein, D. and Vieths, S. (1999) Determination of the allergenic activity of birch pollen and apple prick test solutions by measurement of |
51 | Kambayashi, T. and Koretzky, G. A. (2007) Proximal signaling events in Fc epsilon RI-mediated mast cell activation. J. Allergy Clin. Immunol. 119, 544-552. DOI |
52 | Inagaki, N. and Nagai, H. (2009) Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: mouse models for the development of remedies for human allergic dermatitis. J. Pharmacol. Sci. 110, 251-259. DOI |
53 | Iqbal, N. and Iqbal, N. (2014) Imatinib: a breakthrough of targeted therapy in cancer. Chemother. Res. Pract. 2014, 357027. |
54 | Kagan, R. S. (2003) Food allergy: an overview. Environ. Health Perspect. 111, 223-225. DOI |
55 | Kantarjian, H., Jabbour, E., Grimley, J. and Kirkpatrick, P. (2006) Dasatinib. Nat. Rev. Drug Discov. 5, 717-718. DOI |
56 | Kay, A. B. (2001) Allergy allergic diseases. First of two parts. N. Engl. J. Med. 344, 30-37. DOI |
57 | Schroeder, J. T., MacGlashan, D.W., Jr. and Lichtenstein, L. M. (2001) Human basophils: mediator release and cytokine production. Adv. Immunol. 77, 93-122. |
58 | Rivera, J., Cordero, J. R., Furumoto, Y., Luciano-Montalvo, C., Gonzalez-Espinosa, C., Kovarova, M., Odom, S. and Parravicini, V. (2002) Macromolecular protein signaling complexes and mast cell responses: a view of the organization of IgE-dependent mast cell signaling. Mol. Immunol. 38, 1253-1258. DOI |
![]() |